Drug-induced myopathies.

Z Argov

Journal: Current opinion in neurology 2001;13(5):541-5

PMID: 11073360

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Two major entities continue to be controversial in the field of clinical myotoxicity: the various myopathies that are induced by the cholesterol-lowering agents and the acute quadriplegic myopathy of intensive care. Both conditions are relatively common, but their pathogenesis is unclear. The problematic issues related to these disorders are presented, with suggested topics for future research.

Address: Department of Neurology, Hadassah University Hospital and the Hebrew University-Hadassah Medical School, Jerusalem, Israel. [email protected]

DOI: 10.1097/00019052-200010000-00006

Link outs

Free resources

Medical:

https://medlineplus.gov/muscledisorders.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Acute Disease, Anticholesteremic Agents, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular Diseases, Neuromuscular Blocking Agents, Quadriplegia, Steroids